230 related articles for article (PubMed ID: 12415606)
1. Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapy.
Lahdenne P; Rapola J; Ylijoki H; Haapasaari J
J Rheumatol; 2002 Nov; 29(11):2442-5. PubMed ID: 12415606
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate Hepatotoxicity in Children with Juvenile Idiopathic Arthritis: A Single-Center Study.
Yassin NA; Haroon M; Elhamshary A
Curr Rheumatol Rev; 2021; 17(2):242-246. PubMed ID: 33308133
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate.
Chickermane PR; Khubchandani RP
Clin Exp Rheumatol; 2015; 33(2):287-92. PubMed ID: 25738527
[TBL] [Abstract][Full Text] [Related]
4. The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis.
Hashkes PJ; Balistreri WF; Bove KE; Ballard ET; Passo MH
Arthritis Rheum; 1997 Dec; 40(12):2226-34. PubMed ID: 9416861
[TBL] [Abstract][Full Text] [Related]
5. The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis.
Hashkes PJ; Balistreri WF; Bove KE; Ballard ET; Passo MH
J Pediatr; 1999 Jan; 134(1):47-52. PubMed ID: 9880448
[TBL] [Abstract][Full Text] [Related]
6. Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry.
Foeldvari I; Becker I; Horneff G
Arthritis Care Res (Hoboken); 2015 Nov; 67(11):1529-35. PubMed ID: 25988824
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration.
Fráňová J; Fingerhutová Š; Kobrová K; Srp R; Němcová D; Hoza J; Uher M; Saifridová M; Linková L; Doležalová P
Pediatr Rheumatol Online J; 2016 Jun; 14(1):36. PubMed ID: 27301536
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with methotrexate and cyclosporine A in juvenile idiopathic arthritis.
Ravelli A; Moretti C; Temporini F; Rossi F; Magni-Manzoni S; Pistorio A; Martini A
Clin Exp Rheumatol; 2002; 20(4):569-72. PubMed ID: 12175118
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate/naproxen-associated severe hepatitis in a child with juvenile idiopathic arthritis.
Ting TV; Hashkes PJ
Clin Exp Rheumatol; 2007; 25(6):928-9. PubMed ID: 18173932
[TBL] [Abstract][Full Text] [Related]
10. Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.
Chang CY; Meyer RM; Reiff AO
Arthritis Care Res (Hoboken); 2015 May; 67(5):658-66. PubMed ID: 25220674
[TBL] [Abstract][Full Text] [Related]
11. A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.
Hissink Muller PC; Brinkman DM; Schonenberg D; Koopman-Keemink Y; Brederije IC; Bekkering WP; Kuijpers TW; van Rossum MA; van Suijlekom-Smit LW; van den Berg JM; Allaart CF; Ten Cate R
Pediatr Rheumatol Online J; 2017 Feb; 15(1):11. PubMed ID: 28166785
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and toxicity of methotrexate in juvenile idiopathic arthritis: comparison of 2 initial dosing regimens.
Becker ML; Rosé CD; Cron RQ; Sherry DD; Bilker WB; Lautenbach E
J Rheumatol; 2010 Apr; 37(4):870-5. PubMed ID: 20194449
[TBL] [Abstract][Full Text] [Related]
13. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
[TBL] [Abstract][Full Text] [Related]
14. Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children.
Kyvsgaard N; Mikkelsen TS; Thastum M; Christensen AE; Wehner PS; Nysom K; Herlin T
PLoS One; 2019; 14(7):e0219539. PubMed ID: 31295288
[TBL] [Abstract][Full Text] [Related]
15. The use of methotrexate in children with rheumatic diseases.
Gutiérrez-Suárez R; Burgos-Vargas R
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of concomitant therapy in children with juvenile idiopathic arthritis treated with etanercept and methotrexate.
Alexeeva E; Dvoryakovskaya T; Denisova R; Sleptsova T; Isaeva K; Chomahidze A; Fetisova A; Mamutova A; Alshevskaya A; Gladkikh V; Moskalev A
Pediatr Neonatol; 2019 Oct; 60(5):549-555. PubMed ID: 30885783
[TBL] [Abstract][Full Text] [Related]
17. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate.
Alsufyani K; Ortiz-Alvarez O; Cabral DA; Tucker LB; Petty RE; Malleson PN
J Rheumatol; 2004 Jan; 31(1):179-82. PubMed ID: 14705239
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of liver elasticity with shear-wave elastography in juvenile idiopathic arthritis patients receiving methotrexate.
Özdemir Çiçek S; Karaman ZF; Şahin N; Paç Kısaarslan A; Poyrazoğlu MH; Düşünsel R
Pediatr Int; 2022 Jan; 64(1):e15239. PubMed ID: 36217648
[TBL] [Abstract][Full Text] [Related]
19. A longterm prospective real-life experience with leflunomide in juvenile idiopathic arthritis.
Alcântara AC; Leite CA; Leite AC; Sidrim JJ; Silva FS; Rocha FA
J Rheumatol; 2014 Feb; 41(2):338-44. PubMed ID: 24334641
[TBL] [Abstract][Full Text] [Related]
20. Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate.
Dávila-Fajardo CL; Swen JJ; Cabeza Barrera J; Guchelaar HJ
Pharmacogenomics; 2013 Jan; 14(1):63-73. PubMed ID: 23252949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
